Latest filing published 09 Aug 2011 for Aegerion Pharmaceuticals, Inc., €37k.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Alison Kiley: trading record in brief
All filings by Alison Kiley on record concern Aegerion Pharmaceuticals, Inc. Over a trading history stretching from 27 October 2010 to 9 August 2011, the count stands at 7 filings.
Purchases make up the whole of the open-market record (4 purchases, €4.4M). Unlike grants, an open-market purchase is paid for by the insider, at the market price. 2011 to date brings 2 purchases and no sales.
In size, the median ticket on the buying side is €1.1M.
On 9 August 2011 came the latest disclosure, an open-market purchase for €37k in Aegerion Pharmaceuticals, Inc. The median gap between trade and publication is zero days: most filings appear on the same day. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Alison Kiley
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,200 shares@ US$12.43Common StockSEC:0001209191-11-043226:0Canonical exit: 6 Nov 2011 (T+90)
- 5,500 shares@ US$12.45Common StockSEC:0001209191-11-043226:1Canonical exit: 7 Nov 2011 (T+90)
- 1,186,064 sharesCommon StockSEC:0001181431-10-052254:0
- 414,388 sharesCommon StockSEC:0001181431-10-052254:1
- 764,310 shares@ US$7.60Common StockSEC:0001181431-10-052254:2
5 of 5 declarations
